Assessment of the nodal status in ampullary carcinoma: The number of positive lymph nodes versus the lymph node ratio

World Journal of Surgery

Volumn 35, Issue 9, 2011, Pages 2118-2124

  Sakata, Jun ^a   Shirai, Yoshio ^a   Wakai, Toshifumi ^a   Ajioka, Yoichi ^a   Akazawa, Kouhei ^b   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BILE DUCT TUMOR; CANCER INVASION; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PALLIATIVE THERAPY; PANCREATICODUODENECTOMY; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS; SURVIVAL; TIME; VATER PAPILLA;

ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; ANALYSIS OF VARIANCE; COHORT STUDIES; COMMON BILE DUCT NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PALLIATIVE CARE; PANCREATICODUODENECTOMY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 80052267626     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1175-7     Document Type: Article

References (29)

1. Edge SB, Byrd DR, Compton CC et al (eds) (2010) American Joint Committee on Cancer Staging Manual, 7th edn. Springer, New York, pp 235-240
2. Nagakawa T, Hirata K, Ikeda S et al (eds) (2004) Classification of Biliary Tract Carcinoma. Japanese Society of Biliary Surgery (JSBS). 2nd English edn. Kanehara, Tokyo, pp 51-65
3. J Sakata Y Shirai T Wakai, et al. 2007 Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma Eur J Surg Oncol 33 346 351 17097846 1:STN:280: DC%2BD2s7pvV2mtw%3D%3D (Pubitemid 46488664)
4. Y Shirai K Tsukada T Ohtani, et al. 1996 Carcinoma of the ampulla of Vater: is radical lymphadenectomy beneficial to patients with nodal disease? J Surg Oncol 61 190 194 8637205 10.1002/(SICI)1096-9098(199603)61:3<190::AID- JSO5>3.0.CO;2-6 1:STN:280:DyaK283gslOhug%3D%3D (Pubitemid 26097069)
5. E Bando Y Yonemura K Taniguchi, et al. 2002 Outcome of ratio of lymph node metastasis in gastric carcinoma Ann Surg Oncol 9 775 784 12374661 10.1007/BF02574500
6. AC Berger ER Sigurdson T LeVoyer, et al. 2005 Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes J Clin Oncol 23 8706 8712 16314630 10.1200/JCO.2005.02.8852 (Pubitemid 46211514)
7. TC Böttger J Boddin A Heintz, et al. 1997 Clinicopathologic study for the assessment of resection for ampullary carcinoma World J Surg 21 379 383 10.1007/PL00012257 9143568 10.1007/PL00012257 (Pubitemid 27180998)
8. M Falconi S Crippa I Dominguez, et al. 2008 Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma Ann Surg Oncol 15 3178 3186 18712568 10.1245/s10434-008-0099-4
9. JD Roder PM Schneider HJ Stein, et al. 1995 Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater Br J Surg 82 1693 1696 8548244 10.1002/bjs.1800821235 1:STN:280:DyaK287kvVGjuw%3D%3D
10. M Sierzega K Nowak J Kulig, et al. 2009 Lymph node involvement in ampullary cancer: the importance of the number, ratio, and location of metastatic nodes J Surg Oncol 100 19 24 19384907 10.1002/jso.21283
11. CA Sommerville P Limongelli M Pai, et al. 2009 Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: an analysis of clinicopathological factors J Surg Oncol 100 651 656 19722229 10.1002/jso.21390 1:STN:280:DC%2BD1Mfks1Oqtw%3D%3D
12. D Bogoevski F Onken A Koenig, et al. 2008 Is it time for a new TNM classification in esophageal carcinoma? Ann Surg 247 633 641 18362626 10.1097/SLA.0b013e3181656d07 (Pubitemid 351440614)
13. BP Wijnhoven KT Tran A Esterman, et al. 2007 An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus Ann Surg 245 717 725 17457164 10.1097/01.sla.0000251703.35919.02 (Pubitemid 46684101)
14. A Marchet S Mocellin A Ambrosi, et al. 2007 The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients Ann Surg 245 543 552 17414602 10.1097/01.sla.0000250423.43436.e1 (Pubitemid 46555657)
15. R Rosenberg J Friederichs T Schuster, et al. 2008 Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period Ann Surg 248 968 978 19092341 10.1097/SLA.0b013e318190eddc
16. TM Pawlik AL Gleisner JL Cameron, et al. 2007 Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer Surgery 141 610 618 17462460 10.1016/j.surg.2006.12.013 (Pubitemid 46616937)
17. MG House M Gönen WR Jarnagin, et al. 2007 Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer J Gastrointest Surg 11 1549 1555 17786531 10.1007/s11605-007-0243-7
18. H Saito Y Fukumoto T Osaki, et al. 2007 Prognostic significance of level and number of lymph node metastases in patients with gastric cancer Ann Surg Oncol 14 1688 1693 17245613 10.1245/s10434-006-9314-3 (Pubitemid 46791000)
19. CG Peyre JA Hagen SR DeMeester, et al. 2008 The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg 248 549 556 18936567 10.1097/SLA.0b013e3181904f3c
20. Y Shirai T Ohtani K Tsukada, et al. 1997 Patterns of lymphatic spread of carcinoma of the ampulla of Vater Br J Surg 84 1012 1016 9240155 10.1002/bjs.1800840734 1:STN:280:DyaK2szosVCrtQ%3D%3D (Pubitemid 27310882)
21. Y Shirai T Ohtani K Hatakeyama 1996 Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater [letter] Br J Surg 83 1302 1303 8983635 10.1002/bjs.1800830940 1:STN:280:DyaK2s7gsFCmtQ%3D%3D
22. E Sakata Y Shirai N Yokoyama, et al. 2006 Clinical significance of lymph node micrometastasis in ampullary carcinoma World J Surg 30 985 991 10.1007/s00268-005-7985-8 16736326 10.1007/s00268-005-7985-8 (Pubitemid 43824408)
23. N Yokoyama Y Shirai K Hatakeyama 1999 Immunohistochemical detection of lymph node micrometastases from gallbladder carcinoma using monoclonal anticytokeratin antibody Cancer 85 1465 1469 10193935 10.1002/(SICI)1097- 0142(19990401)85:7<1465::AID-CNCR6>3.0.CO;2-T 1:STN:280: DyaK1M3gvVakug%3D%3D (Pubitemid 29152817)
24. Z Sun GL Zhu C Lu, et al. 2009 The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients Ann Oncol 20 897 905 19179553 10.1093/annonc/mdn707 1:STN:280:DC%2BD1MzgvVymtA%3D%3D
25. UN Maduekwe GY Lauwers C Fernandez-del-Castillo, et al. 2010 New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma Ann Surg Oncol 17 1267 1277 20099040 10.1245/s10434-010-0914-6
26. SL Wong H Ji BK Hollenbeck, et al. 2007 Hospital lymph node examination rates and survival after resection for colon cancer JAMA 298 2149 2154 18000198 10.1001/jama.298.18.2149 1:CAS:528:DC%2BD2sXhtlSksbrN (Pubitemid 350106653)
27. VL Tsikitis DL Larson BG Wolff, et al. 2009 Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved J Am Coll Surg 208 42 47 19228501 10.1016/j.jamcollsurg.2008.10.013
28. ST Kim JO Park J Lee, et al. 2006 A phase II study of gemcitabine and cisplatin in advanced biliary tract cancer Cancer 106 1339 1346 16475213 10.1002/cncr.21741 1:CAS:528:DC%2BD28XjtVCrsbo%3D (Pubitemid 43363912)
29. H Ueno T Okusaka M Ikeda, et al. 2004 Phase II study of S-1 in patients with advanced biliary tract cancer Br J Cancer 91 1769 1774 15505626 10.1038/sj.bjc.6602208 1:CAS:528:DC%2BD2cXpsVOqurg%3D (Pubitemid 39664963)